Bicara Therapeutics (BCAX) Institutional Ownership $12.62 -0.29 (-2.25%) Closing price 01/31/2025 04:00 PM EasternExtended Trading$12.65 +0.03 (+0.27%) As of 01/31/2025 05:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for Bicara Therapeutics (NASDAQ:BCAX)Number ofInstitutional Buyers(last 12 months)25TotalInstitutional Inflows(last 12 months)$397.07MNumber ofInstitutional Sellers(last 12 months)0 Get BCAX Insider Trade Alerts Want to know when executives and insiders are buying or selling Bicara Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BCAX Institutional Buying and Selling by Quarter Bicara Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails1/30/2025 Rhumbline Advisers19,008$331K0.0%N/A0.035% 1/24/2025 Spire Wealth Management1,804$31K0.0%N/A0.003% 1/17/2025 SG Americas Securities LLC8,411$147K0.0%N/A0.015% 11/19/2024Barclays PLC10,000$255K0.0%N/A0.018% 11/18/2024Teachers Retirement System of The State of Kentucky14,039$358K0.0%N/A0.026% 11/16/2024Geode Capital Management LLC48,639$1.24M0.0%N/A0.094% 11/15/2024Barclays PLC10,000$255K0.0%N/A0.019% 11/15/2024Jane Street Group LLC12,151$309K0.0%N/A0.023% 11/15/2024Wellington Management Group LLP763,943$19.46M0.0%N/A1.476% 11/15/2024Soros Fund Management LLC20,000$509K0.0%N/A0.039% Get the Latest News and Ratings for BCAX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bicara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024Samsara BioCapital LLC35,000$891K0.2%N/A0.068% 11/15/2024RA Capital Management L.P.6,955,993$177.17M2.0%N/A13.439% 11/15/2024Point72 DIFC Ltd55,757$1.42M0.0%N/A0.108% 11/15/2024Point72 Asset Management L.P.371,962$9.47M0.0%N/A0.719% 11/15/2024Maven Securities LTD50,000$1.27M0.0%N/A0.097% 11/15/2024Iron Triangle Partners LP200,000$5.09M0.7%N/A0.386% 11/15/2024Janus Henderson Group PLC1,188,191$30.33M0.0%N/A2.296% 11/15/2024Cinctive Capital Management LP9,001$229K0.0%N/A0.017% 11/15/2024Baker BROS. Advisors LP833,333$21.23M0.2%N/A1.610% 11/15/2024Point72 Asia Singapore Pte. Ltd.18,125$462K0.1%N/A0.035% 11/14/2024Braidwell LP1,657,600$42.22M1.2%N/A3.202% 11/14/2024Vestal Point Capital LP425,000$10.83M0.8%N/A0.821% 11/14/2024Walleye Capital LLC31,780$809K0.0%N/A0.061% 11/13/2024FMR LLC2,273,792$57.91M0.0%N/A4.393% 11/13/2024The Manufacturers Life Insurance Company22,859$582K0.0%N/A0.044% 11/7/2024First Turn Management LLC562,391$14.32M2.3%N/A1.087% (Data available from 1/1/2016 forward) BCAX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BCAX shares? During the previous two years, 25 institutional investors and hedge funds held shares of Bicara Therapeutics. The most heavily invested institutionals were RA Capital Management L.P. ($177.17M), FMR LLC ($57.91M), Braidwell LP ($42.22M), Janus Henderson Group PLC ($30.33M), Baker BROS. Advisors LP ($21.23M), Wellington Management Group LLP ($19.46M), and First Turn Management LLC ($14.32M).Learn more on BCAX's institutional investors. Which institutional investors have been buying Bicara Therapeutics stock? Of the 25 institutional investors that purchased Bicara Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($6.96M), FMR LLC ($2.27M), Braidwell LP ($1.66M), Janus Henderson Group PLC ($1.19M), Baker BROS. Advisors LP ($833.33K), Wellington Management Group LLP ($763.94K), and First Turn Management LLC ($562.39K). How much institutional buying is happening at Bicara Therapeutics? Institutional investors have bought a total of 15,598,779 shares in the last 24 months. This purchase volume represents approximately $397.07M in transactions. Related Companies ARWR Institutional Ownership HCM Institutional Ownership MIRM Institutional Ownership CGON Institutional Ownership JANX Institutional Ownership PTGX Institutional Ownership VERA Institutional Ownership HRMY Institutional Ownership IBRX Institutional Ownership CNTA Institutional Ownership This page (NASDAQ:BCAX) was last updated on 2/1/2025 by MarketBeat.com Staff From Our PartnersElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredWill DeepSeek pop the AI bubble?An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump vs. TexasEver since Donald Trump won the election, U.S. states have been rushing to pass new currency rules. These r...Stansberry Research | SponsoredTurning Panic Into OpportunityAI stocks were hammered on Jan. 27. That includes Nvidia, the undisputed leader in the artificial intellige...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredThe #1 Stock for Trump’s First 100 DaysLegendary investor Louis Navellier believes this is just the beginning of Trump's 100-day melt-up. You shou...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bicara Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bicara Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.